Branford, CT, United States of America

Xiaohong Liu

This inventor holds 1 USPTO granted patent. Top assignee: Curagen Corporation. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaohong Liu. Retrieved from https://idiyas.com/inventor/xiaohong-liu-tfbktsqs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 22.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Xiaohong Liu in Branford, CT

Introduction

Xiaohong Liu is a notable inventor based in Branford, CT, recognized for his contributions in the field of biotechnology. With a focus on proteins and nucleic acids, his work is at the forefront of therapeutic and diagnostic advancements.

Latest Patents

Xiaohong Liu holds a patent titled "Proteins, polynucleotides encoding them and methods of using the same." This patent discloses nucleic acid sequences that encode novel polypeptides, along with specific polypeptides and antibodies that bind to these polypeptides. Additionally, the invention presents various derivative forms and outlines research methods for diagnosis, treatment, and prevention of disorders associated with these human nucleic acids and proteins.

Career Highlights

Liu is affiliated with Curagen Corporation, a leading company in genomic technology. His work contributes to pioneering research that addresses critical health issues through innovative solutions within the biotechnological landscape.

Collaborations

During his tenure at Curagen Corporation, Xiaohong Liu has collaborated with esteemed colleagues, including Carol E A Pena and Richard August Shimkets. These partnerships foster an environment of innovation and research excellence.

Conclusion

Xiaohong Liu's inventive work in the biotechnology sector exemplifies the impact of innovation on health and medicine. Through his unique patents and collaborative efforts, he continues to drive advancements that hold potential benefits for various medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…